Thursday, October 31, 2013
Publication and contact
Methyl CpG binding protein 2 (MECP2;
neurons derived from human embryonic stem cells (hESCs)
MECP2-deficient neurons derived from hESCs could be
useful for studying Rett syndrome and screening for therapeutics to treat the
activator-like effector nuclease (TALEN)-based
genome editing was used to generate MECP2-deficient hESCs, which were
then differentiated into neurons. MECP2-deficient neurons showed
impairments in transcriptional activity, protein synthesis, neurite
complexity and protein
kinase B (PKB;
target of rapamycin (mTOR;
pathway signaling, whereas nondeficient isogenic neurons did not. In the MECP2-deficient
neurons, activation of AKT and mTOR signaling rescued impairments in
transcriptional activity, protein synthesis and neuronal complexity. Next
steps could include using the neurons to evaluate therapeutic candidates to
treat Rett syndrome.
Published online Oct. 31, 2013
Patent and licensing status
Li, Y. et al. Cell Stem
published online Oct. 3, 2013;
Contact: Rudolf Jaenisch, Whitehead Institute for Biomedical
Research, Cambridge, Mass.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]